Concert Pharma (CNCE) Reports Q1 Loss of $0.93/Share

Concert Pharma (NASDAQ: CNCE) reported Q1 EPS of ($0.93), versus ($0.19) reported last year. Revenue for the quarter came in at $1 million, versus $10.48 million reported last year.

For earnings history and earnings-related data on Concert Pharma (CNCE) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)
• Femasys Inc. (FEMY) Misses Q2 EPS by 20c